EP4508651A1 — Drug delivery device with electronics
Assigned to Norton Waterford Ltd · Expires 2025-02-19 · 1y expired
What this patent protects
A system may be configured for sending a Uniform Resource Locator (URL) request based on a location of an external device (502). An inhaler (100) may include medicament, an electronics module (120), and/or a Quick Response (QR) code (160). An external device may determine a URL a…
USPTO Abstract
A system may be configured for sending a Uniform Resource Locator (URL) request based on a location of an external device (502). An inhaler (100) may include medicament, an electronics module (120), and/or a Quick Response (QR) code (160). An external device may determine a URL and/or a medicament type of the inhaler (100) based on the QR code (160). The external device may send an indication of the medicament type and/or a location indication to a server that hosts the URL. In response, the external device (502) may receive an application store URL that is specific to the medicament type and/or the location of the external device. The external device may send a request to the application store URL to download software that is specific to the inhaler (100) and/or the medicament type of the inhaler. The application store URL may be specific to a country that the external device is located.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.